Senate Bill S9043

2021-2022 Legislative Session

Relates to coverage for prescription drugs under Medicaid; repealer

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2021-S9043 (ACTIVE) - Details

See Assembly Version of this Bill:
A7200
Current Committee:
Senate Health
Law Section:
Social Services Law
Laws Affected:
Rpld Part FFF §§1 & 1-a, Chap 56 of 2020; add §365-i, rpld §364-j sub 4 ¶(u), subs 25 - 26-b, Soc Serv L; amd §273, Pub Health L
Versions Introduced in 2023-2024 Legislative Session:
S3466

2021-S9043 (ACTIVE) - Summary

Provides that prescription drugs eligible for reimbursement shall be provided and paid for under the preferred drug program and the clinical drug review program; restores pharmacy benefits under Medicaid managed care.

2021-S9043 (ACTIVE) - Sponsor Memo

2021-S9043 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   9043
 
                             I N  S E N A T E
 
                                May 5, 2022
                                ___________
 
 Introduced  by  Sens. RIVERA, REICHLIN-MELNICK -- read twice and ordered
   printed, and when printed to be committed to the Committee on Health
 
 AN ACT to amend the social services law,  in  relation  to  prescription
   drugs  eligible for Medicaid coverage; to amend the public health law,
   in relation to prior authorization under the preferred  drug  program;
   to  repeal certain provisions of part FFF of chapter 56 of the laws of
   2020 directing the department of health to remove the pharmacy benefit
   from the managed care benefit  package,  relating  to  restoring  such
   benefits; and to repeal certain provisions of the social services law,
   relating  to  coverage  for  certain prescription drugs under Medicaid
   managed care programs
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Legislative findings. This legislature finds that the costs
 of  many prescription drugs in the market have been escalating unreason-
 ably. The preferred drug program and the clinical  drug  review  program
 under  the  public  health law provide effective mechanisms for assuring
 access to quality, effective and safe drugs to  patients  at  reasonable
 cost.  Providing  prescription  drugs  to  Medicaid  managed health care
 provider participants through these programs will maximize the  Medicaid
 program's  ability  to  negotiate  more  substantial  rebates  with drug
 manufacturers (effectively, lower  prices),  while  protecting  Medicaid
 managed care provider participants.
   § 2. Sections 1 and 1-a of part FFF of chapter 56 of the laws of 2020,
 relating to prescription drugs under the Medicaid program, are REPEALED.
   §  3. The social services law is amended by adding a new section 365-i
 to read as follows:
   § 365-I. PRESCRIPTION DRUGS IN MEDICAID. 1. THE DEFINITIONS  OF  TERMS
 IN  SECTION  TWO HUNDRED SEVENTY OF THE PUBLIC HEALTH LAW SHALL APPLY TO
 THIS SECTION.   AS USED IN THIS  SECTION,  UNLESS  THE  CONTEXT  CLEARLY
 REQUIRES OTHERWISE, "MANAGED CARE PROVIDER" MEANS A MANAGED CARE PROVID-
 ER  UNDER  SECTION  THREE  HUNDRED  SIXTY-FOUR-J  OF  THIS ARTICLE, OR A
 MANAGED LONG TERM CARE PLAN UNDER SECTION FORTY-FOUR HUNDRED THREE-F  OF
 THE PUBLIC HEALTH LAW.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.